Browse Device Recalls
46 FDA medical device safety recalls.
FDA Medical Device Recall Enforcement Database
Browse 46 FDA medical device recall enforcement actions. Each entry includes the device description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Medical Device Recalls
Browse 46 FDA device recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Sep 2, 2021 | MYLA Versions: 4.7, 4.7.1, 4.8, 4.8.1 and 4.8.2, part of the VIRTUO System | Under certain conditions, there is a risk for a false negative result. | Class II | BioMerieux SA |
| Jun 22, 2021 | MYLA software. Used to manage microbiology test workflow from the reception ... | Software anomaly - Under certain conditions, unwanted alterations to results could be applied whe... | Class II | BioMerieux SA |
| Jan 10, 2020 | NUCLISENS¿ Lysis Buffer, IVD, REF 200292, 48X2 ML LYS Manufacturer bioMerie... | Following a customer complaint about colored eluates, leading to invalid results bioMerieux has c... | Class II | BIOMERIEUX - Grenoble |
| Sep 17, 2018 | NucliSENS¿ Magnetic Extraction Reagents | Data loggers showed that one shipment to the United States experienced low temperatures that may ... | Class II | BioMerieux SA |
| Apr 9, 2018 | VIDAS FSH, Ref 30407-01, IVD, Rx. The firm name on the label is bioMerieux S... | Invalid calibration with low calibrator S1 while using the product. | Class II | BioMerieux SA |
| Mar 23, 2018 | Color Gram 2 (COLOR GRAM 2 - F), these stains are used to stain bacterial and... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Mar 23, 2018 | The PREVI¿ Color Gram dyes are used with the PREVI¿ Color Gram instrument to ... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Mar 23, 2018 | Oxidase Reagent (ref: 55635): This test is used to detect the production of t... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Mar 23, 2018 | The VITEK 2 Gram Negative Susceptibility Card is intended for use with the VI... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Mar 23, 2018 | The VITEK 2 Neisseria-Haemophilus identification card (NH) is intended for us... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Mar 23, 2018 | The VITEK 2 Gram-Positive identification card (GP) is intended for use with t... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Mar 23, 2018 | VIDAS TOXO IgG Avidity is an automated qualitative test for use on the VIDAS ... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Mar 23, 2018 | The VITEK¿ 2 Anaerobic and Corynebacteria identification card (ANC) is intend... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Mar 23, 2018 | The VITEK¿ 2 Gram Positive Susceptibility Card is intended for use with the V... | A shipment to Guadeloupe suffered a temperature excursions up to 47.8¿C, exceeding the acceptable... | Class II | BioMerieux SA |
| Oct 18, 2017 | NucliSENS Lysis Buffer Extended lot for RES 76675 | Elute may become colored due to the residual presence of heme group origination from hemoglobin p... | Class II | BioMerieux SA |
| Apr 25, 2017 | ETEST ETP32 (Ertapenem) Ref. 531640, 531600, blister packaging ETEST is a qu... | False susceptible results | Class II | BioMerieux SA |
| Apr 13, 2017 | ETEST OXACILLIN OX 256 WW F100 In vitro diagnostic, a quantitative techn... | QC failures (MIC out of range high) for S.aureus ATCC 29213 strain on ETEST OX 256 (OXACILLIN) Fo... | Class II | BioMerieux SA |
| Apr 13, 2017 | ETEST OXACILLIN OX 256 US F100 In vitro diagnostic, a quantitative tec... | QC failures (MIC out of range high) for S.aureus ATCC 29213 strain on ETEST OX 256 (OXACILLIN) Fo... | Class II | BioMerieux SA |
| Mar 17, 2017 | VIDAS Estradiol II, Ref 30431-01, 60 tests The VIDAS Estradiol II (E2 II) as... | Fulvestrant cross reacts with the VIDAS Estradiol II immunoassay and may cause falsely elevated e... | Class II | BioMerieux SA |
| Mar 7, 2017 | NucliSENS Lysis Buffer, REF 200292 NucliSENS Lysis Buffer is intended to be ... | Problem with colored eluates for whole blood extractions | Class II | BioMerieux SA |
| Jan 18, 2017 | ETEST XM256 (Cefuroxime), Foam: 506958-506918; SPB: 412304-412305 ETEST is... | Potential performance issues. False Susceptible result instead of Intermediate and False Interme... | Class II | BioMerieux SA |
| Jan 11, 2017 | VIDAS 3 software v. 1.1.4 | During development of the VIDAS 3 software version 1.2, some anomalies have been identified and o... | Class II | BioMerieux SA |
| Jan 1, 2017 | Ceftriaxone TX 32 US S30, Ref 412302 and Ceftriaxone TX 32 US F100, Ref 50705... | Potential performance issue on strain categorization. | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST¿ Ceftriaxone TXL32 SPB, Product Name: ETEST¿ Ceftriaxone TX 0.002-32(lo... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Imipenem IP32 Foam packaging, Product Name: ETEST Imipenem IP 0.002-32.... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Fosfomycin FM1024 Blister packaging, Product Name: ETEST Fosfomycin FM ... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Tobramycin TM256 FOAM packaging, Product Name: ETEST Tobramycin TM 0.01... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Benzyl Penicillin PG256 FOAM packaging, Product Name: Etest Benzylpenic... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Cephalotin CE 256 Foam packaging, Product Name: ETEST Cephalothin CE 0.... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | Ciprofloxacin CI 32 Foam packaging, Product Name: ETEST Ciprofloxacin CI 0.00... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Gentamicin GM256 FOAM packaging, Product Name: ETEST Gentamicin GM 0.01... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Ceftazidime TZ256 Foam packaging, Product Name: ETEST Ceftazidime TZ 0.... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Vancomycin VA 256 FOAM packaging, Product Name: ETEST Vancomycin VA 0.0... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Ceftriaxone TXL32 FOAM packaging, Product Name: ETEST Ceftriaxone TX 0.... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Dec 15, 2016 | ETEST Doripenem DOR32 FOAM packaging, Product Name: Etest Doripenem DOR 0.00... | Product Stability issues: The current shelf-life claims of the ETEST products are not supported ... | Class II | BioMerieux SA |
| Nov 23, 2016 | MagSIL (NucliSENS easyMAG Magnetic Silica), Product Usage: The NucliSENS... | A drift of the performance with the BK test (BK virus, worst case application) was observed for s... | Class I | BioMerieux SA |
| Nov 23, 2016 | NucliSENS magnetic extraction reagents, For in vitro diagnostic use, Prod... | A drift of the performance with the BK test (BK virus, worst case application) was observed for s... | Class I | BioMerieux SA |
| Jul 8, 2016 | NucliSENS easyMAG Magnetic Silica The NucliSENS easyMAG accessory products... | Several customer complaints about amplification performance issues when using different batches o... | Class I | BioMerieux SA |
| Jan 8, 2016 | API ZYM Bx2 (Ref 70493) Product Usage: ZYM B reagent is an additional tes... | Discrepant identification results related to API identification strips. These discrepant identif... | Class II | BioMerieux SA |
| Jun 12, 2015 | Etest Cefotaxime CT 256 WW and Etest Cefotaxime CT 256 US. in vitro diagnostic. | QC results were out of range resulting in false resistant strains. | Class II | BioMerieux SA |
| Mar 6, 2014 | API NIH (REF 10400). ZYM B reagent is used and included inside of API NH (... | bioMerieux identified a visual defect and activity issue on the ZYM B reagent (REF 70493) and FB ... | Class II | BioMerieux SA |
| Mar 6, 2014 | FB Reagent (REF 70562). FB reagent is an additional test used for revealin... | bioMerieux identified a visual defect and activity issue on the ZYM B reagent (REF 70493) and FB ... | Class II | BioMerieux SA |
| Mar 6, 2014 | API Listeria (REF 10300). ZYM B reagent is used and included inside of API... | bioMerieux identified a visual defect and activity issue on the ZYM B reagent (REF 70493) and FB ... | Class II | BioMerieux SA |
| Mar 6, 2014 | ZYM B Reagent (REF 70493). The ZYM B reagent is an additional test used to... | bioMerieux identified a visual defect and activity issue on the ZYM B reagent (REF 70493) and FB ... | Class II | BioMerieux SA |
| Oct 14, 2013 | VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measure... | Product is not approved or authorized for distribution in the US. | Class II | BioMerieux SA |
| Apr 17, 2013 | VIDAS D-Dimer Exclusion II, an automated quantitative test for use on instrum... | Customer complaints about not repeatable results below the detection limit (<45 ng/mL). Therefor... | Class II | BioMerieux SA |
Frequently Asked Questions
When a device safety issue is identified, the manufacturer or FDA initiates a recall. The FDA publishes an enforcement report detailing the device, the reason for the recall, and distribution. Healthcare facilities and providers are notified to check their inventory and take corrective action.
All types — from simple devices like blood glucose test strips and surgical gloves to complex devices like pacemakers, defibrillators, insulin pumps, hip implants, and ventilators. Software-driven devices are increasingly common in recalls due to bugs and cybersecurity vulnerabilities.
Use the search and filter tools on this page. Each recall entry includes the device description, model numbers, and distribution details so you can determine if your device is affected. Contact your healthcare provider if you find a match.